Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(10):660-661; doi:10.1093/jnci/djj205
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hillner, B. E.
Right arrow Articles by Mandelblatt, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hillner, B. E.
Right arrow Articles by Mandelblatt, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press.

EDITORIAL

Caring for Older Women With Breast Cancer: Can Observational Research Fill the Clinical Trial Gap?

Bruce E. Hillner, Jeanne Mandelblatt

Affiliations of authors: Virginia Commonwealth University, Richmond, VA (BEH); Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC (JM)

Correspondence to: Bruce E. Hillner, MD, Virginia Commonwealth University and Massey Cancer Center, 1101 East Marshall St., Sanger Hall Rm. 7-013, Richmond, VA 23298-0170 (e-mail: hillner@vcu.edu).

The first 10% of the full text of this article appears below.

Women aged 65 years or older (herein referred to as "older women") constitute one-half of new breast cancer patients each year (1), and the absolute number of breast cancer cases will double by 2030, with the graying of America (2). Despite their growing numbers, guidelines for appropriate treatment of these older women are limited by the lack of clinical trial data that are specific to this age group, uncertainty about balancing treatment toxicity and benefits, the potential for therapy to amplify preexisting medical conditions, and competing noncancer . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
I. Jatoi, B. E. Chen, W. F. Anderson, and P. S. Rosenberg
Breast Cancer Mortality Trends in the United States According to Estrogen Receptor Status and Age at Diagnosis
J. Clin. Oncol., May 1, 2007; 25(13): 1683 - 1690.
[Abstract] [Full Text] [PDF]